SAUDI ARABIA COMPLETES MERS VACCINE CLINICAL TRIAL

  • 15/11/2021

Riyadh: In collaboration with Oxford University, the King Abdullah International Medical Research Center at the Ministry of National Guard Health Affairs recently completed phase one of the first Saudi clinical study to determine the safety and immunogenicity of the Middle East respiratory syndrome coronavirus vaccine. 


The process began in 2015 with the development of a MERS vaccine through collaboration between the research centre team and Oxford University. The vaccine was tested in the lab and then on mice, which demonstrated the vaccine's immunity and effectiveness, before being transferred for testing in the Kingdom, where the virus has been endemic since its discovery in 2012. 

In a nearly two-year study, the joint research team examined and tested the safety, immunogenicity, and efficacy of the vaccine to be used for immunising camels against the MERS virus. The findings were published in the international scientific journal The Lancet in November, concluding that the vaccine is safe and provides strong immunity.

Related News

Saudi Arabia to launch VAT refund for tourists next year
  • 30/11/2024
Saudi Arabia announces detection of new Corona variant 'JN.1 ...
  • 21/12/2023
Saudi Arabia tells citizens to return from Lebanon
  • 19/10/2023
Saudi Arabia confirms its plan to bid to host 2034 world cup
  • 05/10/2023
Parents could be arrested if students skip school in Saudi
  • 26/08/2023
Iran's top diplomat visits Saudi Arabia's Crown Prince
  • 18/08/2023
Brazil's Neymar signs 2 year contract with Saudi club Al Hil ...
  • 17/08/2023
Cristiano Ronaldo wins his first Arab Cup
  • 14/08/2023
Saudi SCOPA reaches deal with Airbus to develop helicopters ...
  • 19/06/2023
A Saudi man has not slept for 30 years
  • 05/06/2023
Over 16,000 arrested in Saudi last week for violations
  • 24/04/2023
Saudi Arabia’s foreign minister visits Syria for first time ...
  • 18/04/2023